Claire Fraser

Insider Reports History

Entity
Individual
Location
C/O Becton, Dickinson And Company, Franklin Lakes, NJ
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claire Fraser:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BECTON DICKINSON & CO Director Common Stock 22.7K $5.28M $232.46 Jan 23, 2024 Direct
Seres Therapeutics, Inc. Director Stock Option (right to buy 60K Apr 4, 2024 Direct

Insider Reports Filed by Claire Fraser

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MCRB Seres Therapeutics, Inc. Apr 4, 2024 1 $0 4 Apr 8, 2024 Director
BDX BECTON DICKINSON & CO Jan 23, 2024 1 $0 4 Jan 25, 2024 Director
BDX BECTON DICKINSON & CO Aug 28, 2023 1 -$239K 4 Aug 30, 2023 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
BDX BECTON DICKINSON & CO Jan 24, 2023 1 $0 4 Jan 26, 2023 Director
MCRB Seres Therapeutics, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
MCRB Seres Therapeutics, Inc. Jan 4, 2023 0 $0 3 Jan 5, 2023 Director
BDX BECTON DICKINSON & CO Feb 8, 2022 1 -$228K 4 Feb 10, 2022 Director
BDX BECTON DICKINSON & CO Jan 25, 2022 1 $0 4 Jan 27, 2022 Director
BDX BECTON DICKINSON & CO Aug 18, 2021 1 -$97.4K 4 Aug 18, 2021 Director
BDX BECTON DICKINSON & CO May 27, 2021 1 -$94.1K 4 May 28, 2021 Director